| Literature DB >> 29666390 |
Langgeng Agung Waskito1,2, Muhammad Miftahussurur1,2,3, Maria Inge Lusida2, Ari Fahrial Syam4, Rumiko Suzuki1, Phawinee Subsomwong1, Tomohisa Uchida5, Muhammad Hamdan2,6, Yoshio Yamaoka7,8.
Abstract
The clinical associations and correlations with other virulence factors such as cag pathogenicity island (PAI) of the Integrating Conjugative Elements Helicobacter pylori TFSS (ICEHptfs), a new type IV secretion system (TFSS) in H. pylori has not been described. Among 103 studied strains from Indonesia, almost all strains (99.0%) contained cag PAI with more than half (55.8%) were intact cag PAI. Patients infected with intact cag PAI strains showed significantly higher antral activity, inflammation and atrophy as well as corporal inflammation than those with non-intact cag PAI strains, confirming the virulence of cag PAI. Over half of strains (53.8%) contained ICEHptfs, predominantly consisted of ICEHptfs3-tfs4a (42.8%) and ICEHptfs3 (16.3%). Although patients infected with ICEHptfs-positive strains had lower H. pylori density, those with the complete ICEHptfs4b strains tended to have higher antral activity than the negative one. In combination, patients infected with combination of intact cag PAI-ICEHptfs-positive strains had more severe inflammation than those with non-intact cag PAI-ICEHptfs-negative, suggesting a possibility of a mutual correlation between these TFSS(s).Entities:
Mesh:
Substances:
Year: 2018 PMID: 29666390 PMCID: PMC5904169 DOI: 10.1038/s41598-018-24406-y
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Prevalence of ICEHptfs and cag PAI.
| Characteristic | Total (n = 103) | Clinical Outcome (%) | ||
|---|---|---|---|---|
| Gastritis (n = 92) | PUD (n = 10) | Cancer (n = 1) | ||
| 101 (98.0) | 90 (97.8) | 10 (100) | 1 (100) | |
| Intact | 57 (55.4) | 50 (54.3) | 6 (60.0) | 1 (100) |
| non-intact | 45 (43.7) | 41 (44.5) | 4 (40.0) | 0 (0.0) |
| 1 (0.9) | 1 (1.1) | 0 (0.0) | 0 (0.0) | |
| ICE | 56 (54.3) | 51 (55.4) | 5 (50.0) | 0 (0.0) |
|
| ||||
| TFSS3 | 9 (16.0) | 9 (9.7) | 0 (0.0) | 0 (0.0) |
| TFSS4a | 8 (14.4) | 6 (6.5) | 2 (20.0) | 0 (0.0) |
| TFSS4b | 6 (10.7) | 6 (6.5) | 0 (0.0) | 0 (0.0) |
| TFSS3-TFSS4a | 24 (42.8) | 22 (23.9) | 2 (20.0) | 0 (0.0) |
| TFSS3-TFSS4b | 5 (8.9) | 4 (4.3) | 1 (10.0) | 0 (0.0) |
| TFSS3-TFSS4a/b | 4 (7.2) | 4 (4.3) | 0 (0.0) | 0 (0.0) |
Abbreviations: PAI, patogenicity island; TFSS, type IV secretion system; PUD, peptic ulcer disease.
Figure 1Distribution of CagA and CagL hypervariable motif (CagLHM) and the ICEHptfs. (A) The distribution of CagA genotype among Indonesian strains. More than half (58.2%) was East-Asian type CagA. (B) The proportion of ICEHptfs among CagA genotype. It showed the B, ABBD, AABD and ABCC type CagA did not possessed ICEHptfs. (C) The distribution of CagLHM among Indonesian cag PAI positive strains. We observed new CagLHM motif DKMGK. (D) The proportion of ICEHptfs observed in the CagLHM motif group showed all NKIGQ motif (n = 3) contained ICEHptfs elements. The new observed DKMGK motif strains showed the high prevalence (10/11, 90.9%) as high as the DKMGE motif strains (13/14, 92.8%), the progenitor motif of CagLHM.
Distribution of cag PAI and ICEHptfs among Ethnic Group.
| Genetic Profiles | Total (n = 103) | Ethnic Groups (%) | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Javanese (n = 3) | Chinese (n = 9) | Balinese (n = 6) | Bugis (n = 13) | Batak (n = 31) | Papuan (n = 20) | Minahasanese (n = 7) | Dayak (n = 2) | Timor (n = 12) | ||
| ICE | 56 (54.3) | 1 (33.3) | 7 (77.8) | 4 (66.7) | 7 (53.8) | 19 (58.0) | 6 (30.0) | 1 (14.2) | 1 (50.0) | 10 (83.3) |
|
| ||||||||||
| TFSS3 | 9 (16.3) | 0 (0.0) | 4 (57.1) | 1 (25.0) | 2 (28.5) | 2 (11.1) | 0 (0.0) | 0 (0.0) | 1 (100) | 0 (0.0) |
| TFSS4a | 8 (14.5) | 0 (0.0) | 1 (14.2) | 2 (50.0) | 2 (28.5) | 2 (11.1) | 0 (0.0) | 1 (100) | 0 (0.0) | 0 (0.0) |
| TFSS4b | 6 (10.9) | 1 (100) | 0 (0.0) | 0 (0.0) | 1 (14.2) | 1 (5.5) | 1 (16.7) | 0 (0.0) | 0 (0.0) | 2 (20.0) |
| TFSS3-TFSS4a | 24 (43.6) | 0 (0.0) | 1 (14.2) | 1 (50.0) | 2 (28.5) | 14 (77.8) | 3 (50.0) | 0 (0.0) | 0 (0.0) | 3 (30.0) |
| TFSS3-TFSS4b | 4 (7.2) | 0 (0.0) | 1 (14.2) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 1 (16.7) | 0 (0.0) | 0 (0.0) | 2 (20.0) |
| TFSS3-TFSS4a/b | 4 (7.2) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 1 (16.7) | 0 (0.0) | 0 (0.0) | 3 (30.0) |
|
| ||||||||||
| Incomplete TFSS | 32 (57.1) | 1 (33.3) | 5 (71.4) | 3 (75.0) | 6 (85.7) | 9 (47.3) | 4 (66.7) | 1 (100) | 1 (100) | 2 (20.0) |
| Complete TFSS3 | 19 (33.9) | 0 (0.0) | 2 (28.6) | 1 (25.0) | 0 (0.0) | 9 (47.3) | 2 (33.3) | 0 (0.0) | 0 (0.0) | 5 (50.0) |
| Complete TFSS4b | 5 (9.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 1 (14.3) | 1 (5.4) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 3 (30.0) |
|
| ||||||||||
| 101 (98.0) | 3 (100) | 9 (100) | 6 (100) | 12 (92.3) | 31 (100) | 20 (100) | 7 (100) | 2 (100) | 12 (100) | |
| Intact | 57 (55.3) | 0 (0.0) | 3 (33.3) | 5 (83.3) | 8 (72.7) | 16 (51.6) | 11 (55.0) | 2 (28.5) | 2 (100) | 10 (83.3) |
Abbreviations: TFSS, type IV secretion system; PAI, pathogenicity island.
(*) P < 0.05, Fischer’s exact test.
Figure 2Association of cag PAI intactness and the histological findings. Patients infected with the intact cag PAI (n = 53) showed significantly higher antral activity, inflammation and atrophy as well as corporal inflammation than the non-intact counterpart (n = 40).
Association of ICEHptfs status and histology score.
| Histology score | ICE | ICE |
|---|---|---|
|
| ||
| Activity | 1.44 [1.5] | 1.20 [1] |
| Inflammation | 1.82 [2] | 1.79 [2] |
| Atrophy | 1.24 [1] | 1.18 [1] |
| Density* | 1.19 [1] | 1.53 [2] |
|
| ||
| Activity | 0.72 [1] | 0.73 [1] |
| Inflammation | 1.04 [1] | 1.04 [1] |
| Atrophy | 0.32 [0] | 0.28 [0] |
| Density | 1.13 [1] | 1.27 [1] |
(*) P = 0.039, Mann-Whitney U test.
Figure 3Association of ICEHptfs and histological findings in antrum. Patients infected with the complete ICEHptfs4b (n = 4) tended to have higher antral activity than antral activity than the ICEHptfs negative (n = 44).
Association of ICEHptfs and cag PAI status and histology score.
| n | Antrum (Mean [Median]) | Body (Mean [Median]) | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Activity | Inflammation | Atrophy | Density | Activity | Inflammation | Atrophy | Density | ||
|
| |||||||||
| Intact | 34 | 1.75 [2] | 2.25 [2] | 1.47 [1] | 1.45 [1] | 0.75 [1] | 1.13 [1] | 0.38 [0] | 1.25 [1] |
| Intact | 23 | 1.38 [1] | 2.19 [2] | 1.52 [1] | 1.62 [2] | 0.86 [1] | 1.38 [1] | 0.43 [0] | 1.38 [1] |
| Non Intact | 21 | 0.94 [1] | 1.13 [1] | 0.94 [1] | 0.76 [1] | 0.69 [1] | 0.94 [1] | 0.25 [0] | 1.00 [1] |
| Non Intact | 24 | 1.04 [1] | 1.43 [1] | 0.87 [1] | 1.46 [1.5] | 0.63 [1] | 0.75 [1] | 0.17 [0] | 1.17 [1] |
|
| |||||||||
| Intact | 21 | 1.58 [2] | 2.37 [2] | 1.47 [1] | 1.60 [1.5] | 0.53 [1] | 1.11 [1] | 0.32 [0] | 1.21 [1] |
| Intact | 10 | 1.90 [2] | 1.80 [2] | 1.30 [1] | 1.20 [1] | 1.10 [1] | 1.30 [1] | 0.60 [0] | 1.40 [1] |
| Intact | 3 | 2.33 [2] | 3.00 [3] | 2.00 [2] | 1.00 [1] | 1.00 [1] | 0.67 [0] | 0.00 [0] | 1.00 [1] |
| Non intact | 10 | 1.00 [1] | 1.11 [1] | 1.00 [1] | 1.25 [1] | 0.88 [1] | 1.13 [1] | 0.50 [0] | 1.25 [1] |
| Non intact | 9 | 0.83 [0.5] | 1.17 [1.5] | 0.83 [0.5] | 0.75 [0] | 0.43 [0] | 0.71 [1] | 0.00 [0] | 0.83 [0.5] |
| Non intact | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 |
Abbreviations: PAI, Pathogenicity Island, TFSS, type IV secretion system ‡Number samples of this group only one sample. So we cannot calculate the mean and median.